Works matching DE "BREAST tumors"


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf052
    By:
    • Palleschi, Michela;
    • Virga, Alessandra;
    • Scarpi, Emanuela;
    • Fonzi, Eugenio;
    • Musolino, Antonino;
    • Merloni, Filippo;
    • Sarti, Samanta;
    • Danesi, Rita;
    • Ravegnani, Mila;
    • Casadei, Chiara;
    • Sirico, Marianna;
    • Gianni, Caterina;
    • Maltoni, Roberta;
    • Bravaccini, Sara;
    • Calistri, Daniele;
    • Arcangeli, Valentina;
    • Zampiga, Valentina;
    • Cangini, Ilaria;
    • Bandini, Erika;
    • Mannozzi, Francesca
    Publication type:
    Article
    40

    Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf048
    By:
    • Ueno, Naoto T;
    • Cottone, Francesco;
    • Dunton, Kyle;
    • Jacot, William;
    • Yamashita, Toshinari;
    • Sohn, Joohyuk;
    • Tokunaga, Eriko;
    • Prat, Aleix;
    • Tsurutani, Junji;
    • Park, Yeon Hee;
    • Rugo, Hope S;
    • Xu, Binghe;
    • Cardoso, Fatima;
    • Mitri, Zahi;
    • Mahtani, Reshma;
    • Aguilar, Cecilia Orbegoso;
    • Xiao, Feng;
    • Harbeck, Nadia;
    • Cameron, David A;
    • Modi, Shanu
    Publication type:
    Article
    41

    Exploring the anticancer potential of Jerantinine A from Tabernaemontana coronaria against prostate, breast, and ovarian cancers: a computational approach.

    Published in:
    Journal of Complementary & Integrative Medicine, 2025, v. 22, n. 2, p. 363, doi. 10.1515/jcim-2024-0443
    By:
    • Kannappan, Poornima;
    • Kaniyur Chandrasekaran, Meenakshi;
    • Vani Raju, Manikandan;
    • Gopalakrishnan, Shankari;
    • Dhamodharan, Prabhu;
    • Muthaiyan Ahalliya, Rathi;
    • Palanisamy, Chella Perumal;
    • Raju, Balaji;
    • Velliyur Kanniappan, Gopalakrishnan
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Atherosclerosis as a cause of death in patients with cancer: a cohort study.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00353-2
    By:
    • Odat, Ramez M.;
    • Alshwayyat, Sakhr;
    • Nguyen, Dang;
    • Alshwayyat, Tala Abdulsalam;
    • Qasem, Hanan M.;
    • Jain, Hritvik;
    • Hanifa, Hamdah;
    • Aloudat, Osama;
    • Lin, John C.;
    • Ngwa, Wilfred;
    • Thompson, Margaret E. G.;
    • Harky, Amer
    Publication type:
    Article
    48
    49
    50